Spectral sensitivity of photoreceptors mediating phase-shifts of circadian rhythms in retinally degenerate CBA/J (rd/rd) and normal CBA/N (+/+) mice

1996 ◽  
Vol 178 (6) ◽  
Author(s):  
T. Yoshimura ◽  
S. Ebihara
2001 ◽  
Vol 913 (2) ◽  
pp. 165-169 ◽  
Author(s):  
Mark Quigg ◽  
Martin Straume ◽  
Teresa Smith ◽  
Michael Menaker ◽  
Edward H Bertram

Neuroreport ◽  
1995 ◽  
Vol 7 (1) ◽  
pp. 209-212 ◽  
Author(s):  
Elliott G. Marchant ◽  
Ralph E. Mistlberger

1995 ◽  
Vol 695 (2) ◽  
pp. 227-230 ◽  
Author(s):  
Sara J. Eaton ◽  
Niki K. Cote ◽  
Mary E. Harrington

2002 ◽  
Vol 282 (2) ◽  
pp. R454-R463 ◽  
Author(s):  
Katherine M. Sharkey ◽  
Charmane I. Eastman

There has been scant evidence for a phase-shifting effect of melatonin in shift-work or jet-lag protocols. This study tested whether melatonin can facilitate phase shifts in a simulated night-work protocol. Subjects ( n = 32) slept in the afternoons/evenings before night work (a 7-h advance of the sleep schedule). They took melatonin (0.5 mg or 3.0 mg) or placebo before the first four of eight afternoon/evening sleep episodes at a time when melatonin has been shown to phase advance the circadian clock. Melatonin produced larger phase advances than placebo in the circadian rhythms of melatonin and temperature. Average phase advances (±SD) of the dim light melatonin onset were 1.7 ± 1.2 h (placebo), 3.0 ± 1.1 h (0.5 mg), and 3.9 ± 0.5 h (3.0 mg). A measure of circadian adaptation, shifting the temperature minimum enough to occur within afternoon/evening sleep, showed that only subjects given melatonin achieved this goal (73% with 3.0 mg, 56% with 0.5 mg, and 0% with placebo). Melatonin could be used to promote adaptation to night work and jet travel.


1992 ◽  
Vol 598 (1-2) ◽  
pp. 257-263 ◽  
Author(s):  
Johanna H. Meijer ◽  
Benjamin Rusak ◽  
Gabriëlla Gänshirt

Nature ◽  
1984 ◽  
Vol 308 (5955) ◽  
pp. 186-188 ◽  
Author(s):  
Joseph S. Takahashi ◽  
Patricia J. DeCoursey ◽  
Lisa Bauman ◽  
Michael Menaker

1999 ◽  
Vol 19 (15) ◽  
pp. 6637-6642 ◽  
Author(s):  
Mary E. Harrington ◽  
Sabina Hoque ◽  
Adam Hall ◽  
Diego Golombek ◽  
Stephany Biello

1988 ◽  
Vol 255 (6) ◽  
pp. R1055-R1058
Author(s):  
S. T. Inouye ◽  
J. S. Takahashi ◽  
F. Wollnik ◽  
F. W. Turek

The suprachiasmatic nucleus (SCN) of the hypothalamus contains a circadian pacemaker that regulates many circadian rhythms in mammals. Experimental work in microorganisms and invertebrates suggests that protein synthesis is required for the function of the circadian oscillator, and recent experiments in golden hamsters suggest an acute inhibition of protein synthesis can induce phase shifts in a mammalian circadian pacemaker. To determine whether protein synthesis in the SCN region is involved in the generation of circadian rhythms in mammals, a protein synthesis inhibitor, anisomycin, was microinjected into the SCN region, and the effect on the circadian rhythm of locomotor activity of hamsters was measured. A single injection of anisomycin into the SCN region induced phase shifts in the circadian activity rhythm that varied systematically as a function of the phase of injection within the circadian cycle. These results suggest that protein synthesis may be involved in the generation of circadian rhythms in mammals and that the anatomic site of action of anisomycin is within the hypothalamic suprachiasmatic region.


Sign in / Sign up

Export Citation Format

Share Document